Clinical Trials Browser

Phase 2 × Recruiting × Long-Term Synaptic Depression × Clear all

NCT04183712 2024-10-16

Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA

Phase 2 Recruiting

Gastrointestinal

Gallbladder Neoplasms